The Investigation on Cholinesterases and BACE1 Inhibitory Activities in Various Tea Infusions

Uthaiwan SUTTISANSANEE; Thanit KUNKEAW; Natthaphon THATSANASUWAN; Jutamat TONGLIM; Piya TEMVIRIYANUKUL

doi:10.48048/wjst.2019.6221

Authors

Uthaiwan SUTTISANSANEE Institute of Nutrition, Mahidol University, Phutthamonthon, Nakhon Pathom 73170
Thanit KUNKEAW Institute of Nutrition, Mahidol University, Phutthamonthon, Nakhon Pathom 73170
Natthaphon THATSANASUWAN Institute of Nutrition, Mahidol University, Phutthamonthon, Nakhon Pathom 73170
Jutamat TONGLIM Institute of Nutrition, Mahidol University, Phutthamonthon, Nakhon Pathom 73170
Piya TEMVIRIYANUKUL Institute of Nutrition, Mahidol University, Phutthamonthon, Nakhon Pathom 73170

DOI:

https://doi.org/10.48048/wjst.2019.6221

Keywords:

Alzheimer’s disease, anti-cholinesterase activities, assay conditions, Drosophila melanogaster, tea infusion

Abstract

Alzheimer’s disease (AD) is a chronic neurological disease related to the decline in brain and nervous system functions. At present, inhibitions of cholinesterases (ChEs) including acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) to enhance neurotransmitters and retardation of b-amyloid formation through b-secretase (BACE1) inhibition are 2 hypotheses for AD prevention and treatment. Hence, this study aims to investigate inhibitory activities against ChEs of various tea varieties of Camellia sinensis and herbal teas. At this step, the screening methodology for ChEs inhibitory activities in various tea varieties in order to provide a fast, inexpensive and convenient method for the detection of anti-cholinesterase activity was optimized. Then, selected tea with high ChEs was further examined regarding its BACE1 activity. As results, all tea samples displayed both anti-AChE and -BChE activities with the broad ranges of 6 - 85 % and 0 - 72 % inhibitory activities, respectively. Interestingly, C. sinensis teas exhibited higher ChEs inhibitory activities than herbal teas, in exception of Pandanus amaryllifolius (pandan) tea, which exhibited comparable inhibitory activities as C. sinensis teas. Pandan leaves were found to exhibit anti-BACE1 activity with 98 % inhibition. Besides, preliminary in vivo study showed that pandan leaves extract was able to rescue climbing defect observed in AD Drosophila melanogaster model, indicating the potential roles of pandan leaves in AD prevention.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

A Tripathi and UC Srivastava. Acetylcholinesterase: A versatile enzyme of nervous system. Ann. Neurosci. 2008; 15, 106-110.

DM Bowen, CB Smith, P White and AN Davision. Neurotransmitter-related enzymes and indeces of hypoxia in semile dementia and other abiotrophies. Brain Res. 1976; 99, 459-96.

M Pakaski, M Hugyecz, P Santha, G Jancso, A Bjelik, A Domokos, Z Janka and J Kálmán. Capsaicin promotes the amyloidogenic route of brain amyloid precursor protein processing. Neurochem. Int. 2009; 54, 426-30.

NH Greig, T Utsuki, DK Ingram, Y Wang, G Pepeu, C Scali, QS Yu, J mamczarz, HW Holloway, T Giordano, DM Chen, K Furukawa, K Sambamurti, A Brossi and DK Lahiri. Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer -amyloid peptide in rodent. Proc. Natl. Acad. Sci. USA 2005; 102, 17213-8.

SA Mandel, T Amit, O Weinreb, L Reznichenko and MB Youdim. Simultaneous manipulation of multiple brain targets by green tea catechins: A potential neuroprotective strategy for Alzheimer and Parkinson diseases. CNS Neurosci. Ther. 2008; 14, 352-65.

EJ Okello, SU Savelev and EK Perry. In vitro anti-beta-secretase and dual anti-cholinesterase activities of Camellia sinensis L. (tea) relevant to treatment of dementia. Phytother. Res. 2004; 18, 624-7.

GL Ellman, KD Courtney and RM Featherstone. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 1961; 7, 88-95.

AH Jung, BS Min, T Yokozawa, JH Lee, YS Kim and JS Choi. Anti-Alzheimer and antioxidant activities of Coptidis Rhizoma alkaloids. Biol. Pharm. Bull. 2009; 32, 1433-8.

S Jantrapirom, LL Piccolo, H Yoshida and M Yamaguchi. A new Drosophila model of Ubiquilin knockdown shows the effect of impaired proteostasis on locomotive and learning abilities. Exp. Cell Res. 2018; 362, 461-71.

SM Karori, FN Wachira, JK Wanyoko and RM Ngure. Antioxidant capacity of different types of tea products. Afr. J. Biotechnol. 2007; 6, 2287-96.

M Monczor. Diagnosis and treatment of Alzheimer's disease. Cent. Nerv. Syst. Agents Med. Chem. 2005; 5, 5-13.

G Oboh, AJ Akinyemi and AO Ademiluyi. Antioxidant and inhibitory effect of red ginger (Zingiber officinale var. Rubra) and white ginger (Zingiber officinale Roscoe) on Fe(2+) induced lipid peroxidation in rat brain in vitro. Exp. Toxicol. Pathol. 2012; 64, 31-6.

S Maralla and KS Reddy. Effect of aqueous extract of ginger on acetylcholine in brain and its possible role in learning and memory during ethanol withdrawal. Asian J. Pharm. Clin. Res. 2014; 7, 192-8.

BT Tung, DK Thu, NTK Thu and NT Hai. Antioxidant and acetylcholinesterase inhibitory activities of ginger root (Zingiber officinale Roscoe) extract. J. Compl. Integr. Med. 2017; 14, 20160116.

P Rungsaeng, P Sangvanich and A Karnchanatat. Zingipain, a ginger protease with acetylcholinesterase inhibitory activity. Appl. Biochem. Biotechnol. 2013; 170, 934-50.

M Mathew and S Subramanian. In vitro evaluation of anti-Alzheimer effects on dry ginger (Zingiber officinale Roscoe) extract. Indian J. Exp. Biol. 2014; 52, 606-12.

G Oboh, AO Ademiluyi and AJ Akinyemi. Inhibition of acetylcholinesterase activities and some pro-oxidant induced lipid peroxidation in rat brain by two varieties of ginger (Zingiber officinale). Exp. Toxicol. Pathol. 2012; 64, 315-9.

H Tohma, İ Gülçin, E Bursal, AC Gören, SH Alwasel and E Köksal. Antioxidant activity and phenolic compounds of ginger (Zingiber officinale Rosc.) determined by HPLC-MS/MS. Food Measure 2017; 11, 556-66.

S Mošovská, D Nováková and M Kaliňák. Antioxidant activity of ginger extract and identification of its active components. Acta Chim. Slov. 2015; 8, 115-9.

Y Zhao, J Dou, T Wu and HA Aisa. Investigating the antioxidant and acetylcholinesterase inhibition activities of Gossypium herbaceam. Molecules 2013; 18, 951-62.

N Tangsaengvit, W Kitphati, S Tadtong, N Bunyapraphatsara and V Nukoolkarn. Neurite outgrowth and neuroprotective effects of quercetin from Caesalpinia mimosoides Lamk. on cultured P19-derived neurons. Evid Based Compl. Alternat. Med. 2013; 2013, 838051.

D Szwajgier. Anticholinesterase activity of phenolic acids and their derivatives. Z. Naturforsch C 2013; 68, 125-32.

I Orhan, M Kartal, F Tosun and B Şener. Screening of various phenolic acids and flavonoid derivatives for their anticholinesterase potential. Z. Naturforsch 2007; 62, 829-32.

AP Huovila, AJ Turner, M Pelto-Huikko, I Karkkainen and RM Ortiz. Shedding light on ADAM metalloproteinases. Trends Biochem. Sci. 2005; 30, 413-22.

P Anand and B Singh. Flavonoids as lead compounds modulating the enzyme targets in Alzheimer's disease. Med. Chem. Res. 2013; 22, 3061-75.

X Wang, JR Kim, SB Lee, YJ Kim, MY Jung, HW Kwon and YJ Ahn. Effects of curcuminoids identified in rhizomes of Curcuma longa on BACE-1 inhibitory and behavioral activity and lifespan of Alzheimer’s disease Drosophila models. BMC Compl. Alternat. Med. 2014; 14, 88.

C Breda, KV Sathyasaikumar, SS Idrissi, FM Notarangelo, JG Estranero, GGL Moore, EW Green, CP Kyriacou, R Schwarcz and F Giorgini. Tryptophan-2,3-dioxygenase (TDO) inhibition ameliorates neurodegeneration by modulation of kynurenine pathway metabolites. Proc. Natl. Acad. Sci. USA 2016; 113, 5435-40.

QF Liu, JH Lee, YM Kim, S Lee, YK Hong, S Hwang, Y Oh, K Lee, HS Yun, IS Lee, S Jeon, YW Chin, BS Koo and KS Cho. In vivo screening of traditional medicinal plants for neuroprotective activity against Aβ42 cytotoxicity by using Drosophila models of Alzheimer’s disease. Biol. Pharm. Bull. 2015; 38, 1891-901.